A 28-year-old woman with newly diagnosed generalized tonic-clonic seizures presents for treatment initiation. She is planning pregnancy within the next 2 years. Which antiepileptic drug is the preferred first-line choice in this clinical scenario?

Explanation

## First-Line Antiepileptic in Women of Childbearing Age **Key Point:** Lamotrigine is the preferred first-line agent for generalized tonic-clonic seizures in women of reproductive potential due to its favorable teratogenic profile and lack of enzyme induction. ### Why Lamotrigine? **High-Yield:** Lamotrigine has the lowest teratogenic risk among older antiepileptics. The risk of major congenital malformations is approximately 2–3%, comparable to the general population baseline (2–3%), and does NOT increase the risk of cleft palate or cardiac defects. **Clinical Pearl:** Lamotrigine does not induce hepatic enzymes, so it does not reduce oral contraceptive efficacy — critical for women planning pregnancy who need reliable contraception. ### Comparison with Other Agents | Agent | Teratogenic Risk | Key Concern | Enzyme Induction | | --- | --- | --- | --- | | **Lamotrigine** | ~2–3% (lowest) | Rash (1–3%) | No | | Valproic acid | ~15–20% (highest) | Neural tube defects, developmental delay | Yes | | Phenytoin | ~5–10% | Fetal hydantoin syndrome | Yes (strong) | | Phenobarbital | ~7–8% | Developmental delay | Yes (strong) | **Warning:** Valproic acid is contraindicated in women of childbearing age due to its high teratogenic risk (neural tube defects in 1–2%, developmental delay in 30–40% of exposed children) and should be avoided unless absolutely no alternative exists. ### Dosing Consideration Lamotrigine requires slow titration to minimize rash risk (starting 25 mg daily, increasing by 25–50 mg every 1–2 weeks). This is a minor drawback compared to the reproductive safety profile. [cite:KD Tripathi 8e Ch 12]